Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Zimmer Biomet Holdings Inc., 3 years.
Zimmer Biomet Holdings Inc.
Director
ResMed Inc.
Director · Chairman and CEO
Chief executive roles
ResMed Inc.
· Chairman and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Aug 7, 2026 | ResMed Inc. | Open-market sale | −4,991 | $205.69 | $1,026,596 |
| Jul 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Jul 7, 2026 | ResMed Inc. | Open-market sale | −4,991 | $218.55 | $1,090,771 |
| Jun 8, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Jun 8, 2026 | ResMed Inc. | Open-market sale | −4,991 | $193.96 | $968,054 |
| May 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| May 7, 2026 | ResMed Inc. | Open-market sale | −4,991 | $207.82 | $1,037,230 |
| Apr 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Apr 7, 2026 | ResMed Inc. | Open-market sale | −4,991 | $225.50 | $1,125,471 |
| Mar 9, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Mar 9, 2026 | ResMed Inc. | Open-market sale | −4,991 | $251.03 | $1,252,891 |
| Feb 9, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Feb 9, 2026 | ResMed Inc. | Open-market sale | −4,991 | $273.78 | $1,366,436 |
| Jan 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.